Exact Sciences posts wider loss, but sales rise 50%
Kathleen Gallagher of the Journal Sentinel reports: "Madison diagnostic test maker Exact Sciences Corp. reported a wider loss in the fourth quarter on higher revenue. Exact is rolling out its first product after receiving approvals in August from the U.S. Food and Drug Administration and the Centers for Medicare and Medicaid Services." (JOURNAL SENTINEL 2,24)
To access this content, you must purchase a Premium membership, or log in if you are a member.
